HBB and gastric cancer: Moreover, further studies will focus on validating the diagnostic accuracies of another four non-validated potential biomarkers (HBB, TXNRD1, CAKP5, GSPT2) and on analyzing the relationships between the expressed levels of those biomarkers and the prognosis of GC patients.